(BN) Brookfield - Ratings and Ratios
Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA11271J1075
BN: Real Estate, Infrastructure, Energy, Assets, Capital, Equity
Brookfield Corporation is a global leader in alternative asset management, specializing in real estate, renewable power, infrastructure, and private equity. With a strong focus on institutional-grade assets, the firm manages a diverse range of public and private investment vehicles, catering to both retail and institutional clients. Its investment strategy revolves around acquiring high-quality, large-scale assets across various geographies and sectors, leveraging both its own capital and that of external investors.
In the private equity and venture capital space, Brookfield adopts a multi-strategy approach, covering control buyouts, corporate carve-outs, recapitalizations, and investments in underperforming mid-market companies. The firm also engages in operational restructuring, capital structure optimization, and strategic re-direction of portfolio companies. Its private equity investments are concentrated in sectors with significant underlying real assets, such as industrial products, building materials, metals, mining, and manufacturing. This focus on tangible assets provides a layer of stability and downside protection.
Geographically, Brookfield operates across North America (including the U.S., Canada, and Brazil), Europe, Australia, and the Asia-Pacific region. The firm’s equity investments typically range from $2 million to $500 million, with a four-year investment period and a 10-year fund term, extendable by two years. Brookfield prefers to take both minority and majority stakes, depending on the opportunity, allowing it to tailor its involvement to the specific needs of each portfolio company.
Founded in 1997 and headquartered in Toronto, Canada, Brookfield Corporation has established a robust global presence, with offices spanning North America, South America, Europe, the Middle East, and Asia. This extensive network enables the firm to identify and execute on attractive investment opportunities worldwide. For investors and fund managers, Brookfield’s diversified approach, long-term investment horizon, and focus on real assets make it
Additional Sources for BN Stock
BN Stock Overview
Market Cap in USD | 91,784m |
Sector | Financial Services |
Industry | Asset Management |
GiC Sub-Industry | Asset Management & Custody Banks |
IPO / Inception |
BN Stock Ratings
Growth 5y | 63.0% |
Fundamental | -35.8% |
Dividend | 37.8% |
Rel. Strength Industry | 19.9 |
Analysts | - |
Fair Price Momentum | 86.32 CAD |
Fair Price DCF | - |
BN Dividends
Dividend Yield 12m | 0.42% |
Yield on Cost 5y | 0.69% |
Annual Growth 5y | 207.55% |
Payout Consistency | 27.3% |
BN Growth Ratios
Growth Correlation 3m | 32.4% |
Growth Correlation 12m | 95.5% |
Growth Correlation 5y | 64.5% |
CAGR 5y | 12.65% |
CAGR/Max DD 5y | 0.28 |
Sharpe Ratio 12m | 1.64 |
Alpha | 25.60 |
Beta | 1.37 |
Volatility | 28.29% |
Current Volume | 1636.1k |
Average Volume 20d | 1302.9k |
As of February 22, 2025, the stock is trading at CAD 83.72 with a total of 1,636,058 shares traded.
Over the past week, the price has changed by -2.93%, over one month by -2.42%, over three months by +4.26% and over the past year by +55.93%.
Probably not. Based on ValueRay Fundamental Analyses, Brookfield (TO:BN) is currently (February 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -35.75 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BN as of February 2025 is 86.32. This means that BN is currently overvalued and has a potential downside of 3.11%.
Brookfield has no consensus analysts rating.
According to ValueRays Forecast Model, BN Brookfield will be worth about 98.2 in February 2026. The stock is currently trading at 83.72. This means that the stock has a potential upside of +17.33%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 73.1 | -12.7% |
Analysts Target Price | - | - |
ValueRay Target Price | 98.2 | 17.3% |